Rite Aid reopens nine New Orleans locations
CAMP HILL, Pa. Rite Aid on Thursday reported it has reopened nine stores in the New Orleans area that can accommodate both Rite Aid and non-Rite Aid customers. The company continues to open more stores on a daily basis as conditions allow.
Residents displaced by the hurricane can visit any open Rite Aid for their prescriptions because the company’s satellite-linked computer network assures a complete customer prescription history at any Rite Aid store. Because of the state of emergency, Rite Aid pharmacies also can access prescription information for patients who do not normally get their prescriptions at Rite Aid.
In addition, the Rite Aid store at 7060 Veterans Memorial Blvd., Metairie, La. is selling 20-pound ice bags to the public for $4. More than 200,000 pounds of ice were sold in Baton Rouge since Sunday, and two Rite Aid stores there are now selling ice, the company stated. The company will continue to truck in ice and other supplies where most needed.
Relief teams of Rite Aid associates, including store cashiers and pharmacists, have traveled or are traveling from Tennessee and unaffected areas of Louisiana and Alabama to help stores that have been impacted and to help reopen additional stores. Earlier this week, Rite Aid reported it had re-opened 32 stores in these areas.
Teva’s Azilect slows Parkinson’s disease in trials
WASHINGTON Results from a Phase III clinical trial have shown that Teva Pharmaceutical’s Azilect 1-mg tablets can slow the progression of the disease, the drug maker announced.
Researchers gave 1,176 Parkinson’s disease patients daily 1- to 2-mg doses of Azilect for 18 months or a placebo for the first nine months and the drug for the second nine months.
Patients who took the 1-mg dose of Azilect showed significant improvement compared with patients in the placebo group.
The Food and Drug Administration approved Azilect in May 2006 as a monotherapy for early-stage ParkinsonOs disease and as an adjunct therapy to levodopa in moderate-to-advanced stages of the disease.
The drug, known generically as rasagiline mesylate, is available in 30 countries. Danish drug maker Lundbeck markets it in Europe, and both companies plan to co-promote it in the United Kingdom, Germany and France.
Taro to ask for extension on Sun Pharmaceuticals’ offer
TEL AVIV,, Israel Taro Pharmaceutical Industries has said it will appeal to Israel’s Supreme Court to contest a ruling in the Tel Aviv District Court regarding India-based Sun Pharmaceuticals’ offer to acquire the Israeli generic drug maker.
The District Court judge had called Taro’s demand for a tender offer from Sun disingenuous, considering Taro’s acceptance of the offer a year ago.
Taro plans to ask the Supreme Court to extend the deadline for Sun’s offer, which was Tuesday at 5 p.m.